Selzentry (Maraviroc) for HIV | myHIVteam

Connect with others who understand.

sign up Log in
About myHIVteam
Powered By

Selzentry is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with CCR5-tropic HIV-1 in combination with other antiretroviral medications. Selzentry is also referred to by its drug name, Maraviroc, and by the abbreviation MVC. Selzentry is an antiviral medication of the class known as entry inhibitors or CCR5 antagonists. Selzentry is believed to work by preventing HIV from replicating in cells.

How do I take it?
Prescribing information states that Selzentry is taken twice daily. Selzentry comes in tablet form.

Side effects
The FDA-approved label for Selzentry lists common side effects including cold symptoms, fever, rash, cough, and dizziness. Rare but serious side effects listed for Selzentry include severe hypersensitivity reactions and liver, heart, and kidney problems.

For more details about this treatment, visit:

Overview of HIV Treatments – 

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in